Document is current
Any future updates will be listed below
-
Authors
White, Michael J. V. https://orcid.org/0000-0002-9615-2249
Raczy, Michal M. https://orcid.org/0000-0001-8400-2051
Budina, Erica https://orcid.org/0000-0001-8510-0497
Yuba, Eiji
Solanki, Ani https://orcid.org/0000-0002-7190-7852
Shim, Ha-Na
Zhang, Zheng Jenny https://orcid.org/0000-0001-6469-5778
Gray, Laura T.
Cao, Shijie
Alpar, Aaron T.
Hubbell, Jeffrey A. https://orcid.org/0000-0003-0276-5456
- License Information
-
More Information
Article History
Received: 18 February 2024
Accepted: 11 March 2025
First Online: 17 April 2025
Declarations
:
: JAH is founder and shareholder of HeioThera, Inc, which has licensed the variants of IL-10 described herein from the University of Chicago. The other authors declare that they have no competing interests.
: All the animal experiments performed in this work were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Chicago, and was reported in this manuscript using ARRIVE guidelines. All mouse experiments were performed under supervision with protocols approved by the University of Chicago IACUC, and the study was performed in accordance with the relevant guidelines and regulations.
